Aligos Therapeutics (ALGS) Stock Chart & Stock Price History $5.62 -0.43 (-7.04%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Aligos Therapeutics Stock Price Performance 5 Day Performance+3.12%1 Month Performance-25.86%3 Month Performance-78.22%6 Month Performance-41.15%Year-To-Date Performance-85.89%1 Year Performance-73.43% Receive ALGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ALGS Stock Chart for Friday, May, 2, 2025 ALGS Chart by TradingView Aligos Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$5.58$6.03+8.06%$6.32$5.46124,581 shs$36.87 million04/30/2025$5.25$5.58+6.29%$5.58$4.7767,519 shs$34.12 million04/29/2025$5.30$5.25-0.94%$5.55$5.1756,022 shs$32.10 million04/28/2025$5.45$5.30-2.75%$5.59$5.1069,543 shs$32.40 million04/25/2025$5.83$5.45-6.52%$6.00$5.38124,251 shs$33.32 million04/24/2025$5.36$5.83+8.77%$5.90$5.28142,933 shs$35.65 million04/23/2025$5.14$5.36+4.28%$5.94$5.21155,787 shs$32.77 million04/22/2025$4.62$5.14+11.26%$5.19$4.5597,847 shs$31.43 million04/21/2025$4.68$4.62-1.28%$4.83$4.43111,356 shs$28.25 million04/18/2025$4.68$4.68$4.79$4.4278,994 shs$28.61 million Get the Latest News and Ratings for ALGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$4.57$4.68+2.41%$4.79$4.4278,994 shs$28.61 million04/16/2025$4.72$4.57-3.18%$4.97$4.3398,881 shs$27.94 million04/15/2025$4.61$4.72+2.39%$5.67$4.60267,650 shs$28.86 million04/14/2025$4.08$4.61+12.99%$4.77$4.13125,974 shs$28.19 million04/11/2025$3.99$4.08+2.26%$4.35$3.76256,613 shs$24.95 million04/10/2025$5.03$3.99-20.68%$4.98$3.92309,543 shs$24.40 million04/09/2025$4.71$5.03+6.79%$5.19$4.27259,560 shs$30.75 million04/09/2025$4.71$5.03+6.79%$5.19$4.27259,560 shs$30.75 million04/08/2025$5.05$4.71-6.73%$5.79$4.51209,715 shs$28.80 million04/08/2025$5.05$4.71-6.73%$5.79$4.51209,715 shs$28.80 million04/07/2025$5.95$5.05-15.13%$5.73$4.81427,734 shs$30.88 million04/04/2025$6.48$5.95-8.18%$6.10$5.05542,825 shs$36.38 million04/03/2025$7.58$6.48-14.51%$6.99$6.42122,571 shs$39.62 million04/02/2025$7.14$7.58+6.16%$7.91$6.9684,481 shs$46.34 million04/01/2025$8.25$7.14-13.45%$8.61$7.03116,839 shs$43.65 million Related Companies Protara Therapeutics Stock Chart Compugen Stock Chart SELLAS Life Sciences Group Stock Chart Neumora Therapeutics Stock Chart scPharmaceuticals Stock Chart RAPT Therapeutics Stock Chart Enanta Pharmaceuticals Stock Chart Coherus BioSciences Stock Chart Contineum Therapeutics Stock Chart C4 Therapeutics Stock Chart Receive ALGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALGS) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aligos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aligos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
